FH-causative variants lead to an increased PCSK9 activity (Gain-of-function—GOF), whereas those leading to a decreased PCSK9 activity (Loss-of-function—LOF) are causative of decreased LDL-cholesterol levels [24]. Here, PCSK9 is linked to familial hyperaldosteronism.